Compare ARTL & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTL | IZM |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | China |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.5M |
| IPO Year | N/A | 2021 |
| Metric | ARTL | IZM |
|---|---|---|
| Price | $1.00 | $0.34 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 187.8K | ★ 1.4M |
| Earning Date | 05-13-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.39 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.98 | $0.26 |
| 52 Week High | $28.60 | $2.74 |
| Indicator | ARTL | IZM |
|---|---|---|
| Relative Strength Index (RSI) | 26.93 | 45.51 |
| Support Level | N/A | $0.32 |
| Resistance Level | $1.87 | $0.47 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 1.58 | 35.36 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.